Jeffrey B. Mirviss is President & VP at BOSTON SCIENTIFIC CORP (BSX). They have made 30 open-market trades across 1 company since 2013, most recently 2025-02-25.
CIK 0001566094
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 30 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BSX | 28,454 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2025-02-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BSX | SELL · 10b5-1 | 2025-02-24 | 2025-02-25 | $104.19 | $1.3M | -1.3% | +0.4% | +5.7% |
| BSX | SELL · 10b5-1 | 2025-02-19 | 2025-02-19 | $105.35 | $318K | -0.5% | -4.5% | +1.1% |
| BSX | SELL · 10b5-1 | 2025-02-12 | 2025-02-13 | $105.06 | $2.7M | -4.3% | -6.8% | -3.0% |
| BSX | SELL · 10b5-1 | 2025-01-03 | 2025-01-03 | $89.86 | $1.3M | +8.3% | +13.7% | +8.6% |
| BSX | SELL · 10b5-1 | 2024-05-29 | 2024-05-30 | $75.10 | $9.6M | +2.6% | +1.6% | +5.8% |
| BSX | SELL · 10b5-1 | 2024-03-18 | 2024-03-19 | $66.45 | $1.9M | +0.6% | -0.4% | +12.5% |
| BSX | SELL · 10b5-1 | 2024-02-21 | 2024-02-22 | $66.35 | $329K | +0.2% | +0.6% | +12.7% |
| BSX | SELL · 10b5-1 | 2024-01-09 | 2024-01-10 | $59.25 | $899K | +1.7% | +9.9% | +15.2% |
| BSX | SELL · 10b5-1 | 2024-01-04 | 2024-01-05 | $58.40 | $876K | +4.5% | +10.4% | +16.0% |
| BSX | SELL · 10b5-1 | 2024-01-03 | 2024-01-04 | $57.82 | $1.4M | +5.1% | +11.2% | +17.5% |
| BSX | SELL · 10b5-1 | 2023-12-06 | 2023-12-07 | $55.03 | $19K | +1.7% | +6.5% | +22.9% |
| BSX | SELL · 10b5-1 | 2023-08-28 | 2023-08-30 | $53.48 | $2.0M | -2.1% | -3.2% | +0.7% |
| BSX | SELL | 2023-04-05 | 2023-04-06 | $50.40 | $494K | +6.0% | +6.5% | +6.7% |
| BSX | SELL | 2023-03-30 | 2023-03-31 | $49.60 | $486K | +3.0% | +5.6% | +6.6% |
| BSX | SELL | 2023-02-21 | 2023-02-22 | $46.23 | $368K | +2.4% | +3.5% | +10.5% |
| BSX | SELL | 2023-02-16 | 2023-02-21 | $46.53 | $323K | +3.8% | +4.1% | +16.5% |
| BSX | SELL | 2023-01-04 | 2023-01-04 | $46.38 | $626K | -0.6% | +4.7% | +8.1% |
| BSX | SELL | 2022-12-12 | 2022-12-13 | $46.75 | $518K | -2.4% | -1.0% | +0.8% |
| BSX | SELL | 2022-12-09 | 2022-12-12 | $46.15 | $3.8M | -3.4% | -4.1% | -0.4% |
| BSX | SELL | 2022-04-20 | 2022-04-21 | $46.50 | $897K | -8.8% | -12.9% | -18.6% |
| BSX | SELL | 2022-04-19 | 2022-04-20 | $45.50 | $1000K | -12.0% | -17.1% | -20.3% |
| BSX | SELL | 2022-03-22 | 2022-03-23 | $44.50 | $500K | +4.2% | +3.6% | -14.3% |
| BSX | SELL | 2022-01-04 | 2022-01-05 | $43.54 | $596K | +2.6% | -0.8% | +2.9% |
| BSX | SELL | 2021-07-27 | 2021-07-27 | $45.22 | $610K | -1.6% | -1.7% | -2.0% |
| BSX | SELL | 2021-04-28 | 2021-04-29 | $43.98 | $4.3M | -3.0% | -2.1% | +3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.